Jim Simons Concert Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$4.34 - $5.84 $616,280 - $829,280	-142,000 Reduced 22.1%	500,605 $2.92 Million
Q3 2022 Nov 14, 2022	SELL	$4.27 - $7.2 $1.22 Million - $2.06 Million	-285,579 Reduced 30.77%	642,605 $4.31 Million
Q2 2022 Aug 12, 2022	BUY	$2.8 - $6.36 $1.41 Million - $3.19 Million	501,879 Added 117.73%	928,184 $3.91 Million
Q1 2022 May 13, 2022	SELL	$2.73 - $3.94 $408,135 - $589,030	-149,500 Reduced 25.96%	426,305 $1.44 Million
Q4 2021 Feb 11, 2022	SELL	$2.69 - $4.22 $461,590 - $724,130	-171,595 Reduced 22.96%	575,805 $1.81 Million
Q3 2021 Nov 12, 2021	SELL	$3.17 - $4.15 $778,552 - $1.02 Million	-245,600 Reduced 24.73%	747,400 $2.44 Million
Q2 2021 Aug 13, 2021	BUY	$3.77 - $5.24 $263,055 - $365,626	69,776 Added 7.56%	993,000 $4.19 Million
Q1 2021 May 13, 2021	BUY	$4.86 - $13.07 $1.69 Million - $4.54 Million	347,124 Added 60.25%	923,224 $4.61 Million
Q4 2020 Feb 10, 2021	SELL	$9.48 - $12.84 $479,688 - $649,704	-50,600 Reduced 8.07%	576,100 $7.28 Million
Q3 2020 Nov 13, 2020	SELL	$8.67 - $10.82 $149,991 - $187,186	-17,300 Reduced 2.69%	626,700 $6.15 Million
Q2 2020 Aug 13, 2020	BUY	$7.8 - $11.52 $226,200 - $334,080	29,000 Added 4.72%	644,000 $6.41 Million
Q1 2020 May 14, 2020	SELL	$5.98 - $13.09 $116,012 - $253,946	-19,400 Reduced 3.06%	615,000 $5.44 Million
Q4 2019 Feb 13, 2020	BUY	$5.71 - $9.22 $94,843 - $153,144	16,610 Added 2.69%	634,400 $5.85 Million
Q3 2019 Nov 13, 2019	BUY	$5.88 - $12.35 $10,525 - $22,106	1,790 Added 0.29%	617,790 $3.63 Million
Q2 2019 Aug 12, 2019	SELL	$9.44 - $13.12 $826,944 - $1.15 Million	-87,600 Reduced 12.45%	616,000 $7.39 Million
Q1 2019 May 14, 2019	BUY	$12.07 - $17.54 $182,257 - $264,854	15,100 Added 2.19%	703,600 $8.49 Million
Q4 2018 Feb 13, 2019	BUY	$11.25 - $16.17 $7.75 Million - $11.1 Million	688,500 New	688,500 $8.64 Million

Others Institutions Holding CNCE

# of Institutions

Shares Held

Call Options Held

Put Options Held

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About CONCERT PHARMACEUTICALS, INC.

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

More about CNCE

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account